{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:58:32Z","timestamp":1792047512587,"version":"4.4.0"},"reference-count":80,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pulmonary hypertension (PH) is a progressive and potentially fatal complication of sickle cell disease (SCD), affecting 6\u201310% of adult SCD patients. Various mechanisms and theories have been evaluated to explain the pathophysiology of this disease. However, questions remain, particularly regarding the clinical heterogeneity of the disease in terms of symptoms, complications, and survival. Beyond the classical mechanisms that have been thoroughly investigated and include hemolysis, nitric oxide availability, endothelial disorders, thrombosis, and left heart failure, attention is currently focused on the potential role of genes involved in such processes. Potential candidate genes are investigated through next-generation sequencing, with the transforming growth factor-beta (TGF-\u03b2) pathway being the initial target. This field of research may also provide novel targets for pharmacologic agents in the future, as is already the case with idiopathic PH. The collection and processing of data and samples from multiple centers can yield reliable results that will allow a better understanding of SCD-related PH as a part of the disease\u2019s clinical spectrum. This review attempts to capture the most recent findings of studies on gene polymorphisms that have been associated with PH in SCD patients.<\/jats:p>","DOI":"10.3390\/ijms25094792","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T15:05:01Z","timestamp":1715007901000},"page":"4792","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-5805","authenticated-orcid":false,"given":"Sevastianos","family":"Chatzidavid","sequence":"first","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Center of Expertise in Rare Hematological Diseases (Hemoglobinopathies), Laikon General Hospital Member of EuroBlood NET, 16 Sevastoupoleos Str., 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8638-7944","authenticated-orcid":false,"given":"Pagona","family":"Flevari","sequence":"additional","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Center of Expertise in Rare Hematological Diseases (Hemoglobinopathies), Laikon General Hospital Member of EuroBlood NET, 16 Sevastoupoleos Str., 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tombrou","sequence":"additional","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Center of Expertise in Rare Hematological Diseases (Hemoglobinopathies), Laikon General Hospital Member of EuroBlood NET, 16 Sevastoupoleos Str., 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Anastasiadis","sequence":"additional","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Center of Expertise in Rare Hematological Diseases (Hemoglobinopathies), Laikon General Hospital Member of EuroBlood NET, 16 Sevastoupoleos Str., 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dimopoulou","sequence":"additional","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Center of Expertise in Rare Hematological Diseases (Hemoglobinopathies), Laikon General Hospital Member of EuroBlood NET, 16 Sevastoupoleos Str., 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary Complications of Sickle Cell Disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1900585","DOI":"10.1183\/13993003.00585-2019","article-title":"Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease","volume":"54","author":"Savale","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gladwin, M.T., Barst, R.J., Gibbs, J.S.R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K.L., Little, J.A., Schraufnagel, D.E., and Krishnamurti, L. (2014). Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099489"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2011.08777.x","article-title":"NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease","volume":"154","author":"Machado","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in Adults with Sickle Cell Disease and Pulmonary Hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: Cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","article-title":"Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease","volume":"187","author":"Mehari","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2967\/jnumed.118.211466","article-title":"Abnormal Ventilation\u2013Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults","volume":"60","author":"Mehari","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2017-02-767624","article-title":"Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia","volume":"130","author":"Niss","year":"2017","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3324\/haematol.2015.125229","article-title":"Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease","volume":"101","author":"Nguyen","year":"2015","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease","volume":"365","author":"Parent","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jama.296.3.310","article-title":"N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease","volume":"296","author":"Machado","year":"2006","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.200610-1498OC","article-title":"Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension","volume":"175","author":"Anthi","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3324\/haematol.13812","article-title":"Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: Association with hemolysis and hemoglobin oxygen desaturation","volume":"94","author":"Minniti","year":"2009","journal-title":"Haematologica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","article-title":"Pulmonary hypertension and nitric oxide depletion in sickle cell disease","volume":"116","author":"Bunn","year":"2010","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MCP.0000000000000795","article-title":"The different facets of sickle cell disease-related pulmonary hypertension","volume":"27","author":"Prohaska","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1038\/s41598-022-14307-6","article-title":"Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension","volume":"12","author":"Tang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcmg.2015.05.013","article-title":"Cardiomyopathy with Restrictive Physiology in Sickle Cell Disease","volume":"9","author":"Niss","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.21952","article-title":"Reconstructing sickle cell disease: A data-based analysis of the \u201chyperhemolysis paradigm\u201d for pulmonary hypertension from the perspective of evidence-based medicine","volume":"86","author":"Hebbel","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: The nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.2304002","article-title":"Hemolytic Anemia\u2013associated Pulmonary Hypertension of Sickle Cell Disease and the Nitric Oxide\/Arginine Pathway","volume":"168","author":"Jison","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.2009.07658.x","article-title":"Endogenous nitric oxide synthase inhibitors in sickle cell disease: Abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death","volume":"145","author":"Kato","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.110.988089","article-title":"Pulmonary Hypertension Associated with Hemoglobinopathies","volume":"123","author":"Farmakis","year":"2011","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/bloodadvances.2019000193","article-title":"Role of the coagulation system in the pathogenesis of sickle cell disease","volume":"3","author":"Nasimuzzaman","year":"2019","journal-title":"Blood Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3324\/haematol.2019.239350","article-title":"The molecular basis for the prothrombotic state in sickle cell disease","volume":"105","author":"Shet","year":"2020","journal-title":"Haematologica"},{"key":"ref_36","first-page":"27100","article-title":"Silent Cerebral Ischemia and Thromboembolic Events in Sickle Cell Disease: Analysis of Coagulation Parameters and Thromboelastography","volume":"102","author":"Dimopoulou","year":"2017","journal-title":"Haematologica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00277-023-05099-4","article-title":"Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: A single-center cross-sectional study","volume":"102","author":"Tantawy","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_38","first-page":"219","article-title":"Sleep Disorders in Adult Sickle Cell Patients","volume":"11","author":"Sharma","year":"2015","journal-title":"Sleep Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.chest.2015.11.016","article-title":"Chronic Pulmonary Complications of Sickle Cell Disease","volume":"149","author":"Mehari","year":"2016","journal-title":"Chest"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1800272","DOI":"10.1183\/13993003.00272-2018","article-title":"Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease","volume":"52","author":"Turpin","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension","volume":"130","author":"Machado","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ejh.13612","article-title":"Long Term Tolerability of Sildenafil in Sickle Cell Disease. Retrospective study evaluating the effect of phosphodiesterase 5 inhibitors in patients with SCD-related PH confirmed on RHC","volume":"107","author":"Ruhl","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2045894018791802","DOI":"10.1177\/2045894018791802","article-title":"Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series","volume":"8","author":"Weir","year":"2018","journal-title":"Pulm. Circ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2141.2009.07906.x","article-title":"Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease","volume":"147","author":"Minniti","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: Results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: Cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.3324\/haematol.2015.131227","article-title":"Prostacyclin-analog therapy in sickle cell pulmonary hypertension","volume":"102","author":"Weir","year":"2017","journal-title":"Haematologica"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: An international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcyt.2018.04.003","article-title":"Gene therapy for sickle cell disease: An update","volume":"20","author":"Demirci","year":"2018","journal-title":"Cytotherapy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1182\/blood-2007-02-074849","article-title":"Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease","volume":"111","author":"Elliott","year":"2008","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V114.22.2562.2562","article-title":"Genetic Polymorphisms in NEDD4L Are Associated with Pulmonary Hypertension of Sickle Cell Anemia","volume":"114","author":"Klings","year":"2009","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1152\/physiol.00023.2023","article-title":"Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2","volume":"39","author":"Rotin","year":"2024","journal-title":"Physiology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood.V114.22.903.903","article-title":"Cytochrome b5 Reductase T116S Mutation and Hemolysis in Sickle Cell Disease","volume":"114","author":"Nouraie","year":"2009","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood.V116.21.4233.4233","article-title":"Cytochrome B5 Reductase T116S Polymorphism Is Associated with Decreased Risk of Severe Anemia Among Zambian Children with Malaria","volume":"116","author":"Gordeuk","year":"2010","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1164\/rccm.201201-0057OC","article-title":"A Novel Molecular Signature for Elevated Tricuspid Regurgitation Velocity in Sickle Cell Disease","volume":"186","author":"Desai","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/omi.2016.0125","article-title":"Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa","volume":"20","author":"Geard","year":"2016","journal-title":"OMICS A J. Integr. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3892\/ijo.2016.3796","article-title":"Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis","volume":"50","author":"Nogimori","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13148-022-01370-z","article-title":"Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer","volume":"14","author":"Shozu","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10456-020-09728-8","article-title":"Tumor-derived exosomes promote angiogenesis via adenosine A2B receptor signaling","volume":"23","author":"Ludwig","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/CIRCULATIONAHA.113.005296","article-title":"Hypoxic Response Contributes to Altered Gene Expression and Precapillary Pulmonary Hypertension in Patients with Sickle Cell Disease","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1179\/1607845415Y.0000000013","article-title":"Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients","volume":"20","author":"Ellithy","year":"2015","journal-title":"Hematology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10245332.2016.1142710","article-title":"Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease","volume":"21","author":"Yousry","year":"2016","journal-title":"Hematology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"L541","DOI":"10.1152\/ajplung.00282.2011","article-title":"Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension","volume":"302","author":"Maloney","year":"2012","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_67","first-page":"E31","article-title":"Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia","volume":"92","author":"Jacob","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/674754","article-title":"Cellular, Pharmacological, and Biophysical Evaluation of Explanted Lungs from a Patient with Sickle Cell Disease and Severe Pulmonary Arterial Hypertension","volume":"3","author":"Rogers","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.gendis.2016.09.002","article-title":"Polymorphism of the endothelin-1 gene (rs5370) is a potential contributor to sickle cell disease pathophysiology","volume":"3","author":"Navarro","year":"2016","journal-title":"Genes Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e22264","DOI":"10.1002\/jcla.22264","article-title":"Protein Z and Endothelin-1 genetic polymorphisms in pediatric Egyptian sickle cell disease patients","volume":"32","author":"Khorshied","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_71","first-page":"119","article-title":"Endothelin-1 but not Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with Sickle Cell Disease in Africa","volume":"8","author":"Thakur","year":"2014","journal-title":"Gene Regul. Syst. Biol."},{"key":"ref_72","first-page":"35","article-title":"IL-I\u03b2 +3954 C\/T Polymorphism and Its Clinical Associations in Egyptian Sickle Cell Disease Patients","volume":"13","author":"Afifi","year":"2019","journal-title":"Int. J. Hematol. Stem Cell Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bcmd.2014.12.004","article-title":"Interleukin-1\u03b2 and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia","volume":"54","author":"Vicari","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tracli.2019.01.003","article-title":"Association between MTHFR 677C>T polymorphism and vascular complications in sickle cell disease: A meta-analysis","volume":"26","author":"Lakkakula","year":"2019","journal-title":"Transf. Clin. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e12227","DOI":"10.1002\/pul2.12227","article-title":"RASA3 is a candidate gene in sickle cell disease-associated pulmonary hypertension and pulmonary arterial hypertension","volume":"13","author":"Prohaska","year":"2023","journal-title":"Pulm. Circ."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/ehm.10.44","article-title":"Genomic polymorphisms in sickle cell disease: Implications for clinical diversity and treatment","volume":"3","author":"Fertrin","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","article-title":"Genetic Etiologies for Phenotypic Diversity in Sickle Cell Anemia","volume":"9","author":"Steinberg","year":"2009","journal-title":"Sci. World J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3324\/haematol.2018.198887","article-title":"Sotatercept, a novel transforming growth factor \u03b2 ligand trap, improves anemia in \u03b2-thalassemia: A phase II, open-label, dose-finding study","volume":"104","author":"Cappellini","year":"2018","journal-title":"Haematologica"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"E416","DOI":"10.1002\/ajh.26323","article-title":"The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies","volume":"96","author":"Kountouris","year":"2021","journal-title":"Am. J. Hematol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4792\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:34:50Z","timestamp":1760106890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":80,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25094792"],"URL":"https:\/\/doi.org\/10.3390\/ijms25094792","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]}}}